Azithromycin as a cause of QT-interval prolongation and torsade de pointes in the absence of other known precipitating factors

Anna Kezerashvili; Himad Khattak; Aron Barsky; Reza Nazari; John D Fisher

doi:10.1007/s10840-007-9124-y

Azithromycin as a cause of QT-interval prolongation and torsade de pointes in the absence of other known precipitating factors

J Interv Card Electrophysiol. 2007 Apr;18(3):243-6. doi: 10.1007/s10840-007-9124-y. Epub 2007 Jun 2.

Authors

Anna Kezerashvili¹, Himad Khattak, Aron Barsky, Reza Nazari, John D Fisher

Affiliation

¹ Department of Medicine, Cardiology Division, Arrhythmia Service, Montefiore Medical Center/Cardiology-N2, Albert Einstein College of Medicine, Bronx, NY 10467, USA.

PMID: 17546486
DOI: 10.1007/s10840-007-9124-y

Abstract

During treatment with azithromycin, a 55 year-old woman developed a newly prolonged QT interval and torsade de pointes in the absence of known risk factors. Female gender and acute renal failure may be considerations in patients treated with azithromycin.

Publication types

Case Reports

MeSH terms

Anti-Bacterial Agents / adverse effects*
Azithromycin / adverse effects*
Bradycardia / therapy
Female
Humans
Long QT Syndrome / chemically induced*
Middle Aged
Pacemaker, Artificial
Torsades de Pointes / chemically induced*

Substances

Anti-Bacterial Agents
Azithromycin